IL59628A - 4-amino-3-quinolinecarboxylic acids and salts and esters thereof and pharmaceutical compositions containing them - Google Patents
4-amino-3-quinolinecarboxylic acids and salts and esters thereof and pharmaceutical compositions containing themInfo
- Publication number
- IL59628A IL59628A IL59628A IL5962880A IL59628A IL 59628 A IL59628 A IL 59628A IL 59628 A IL59628 A IL 59628A IL 5962880 A IL5962880 A IL 5962880A IL 59628 A IL59628 A IL 59628A
- Authority
- IL
- Israel
- Prior art keywords
- esters
- salts
- amino
- pharmaceutical compositions
- compositions containing
- Prior art date
Links
- UEFKMJWKPVAVND-UHFFFAOYSA-N 4-aminoquinoline-3-carboxylic acid Chemical class C1=CC=C2C(N)=C(C(O)=O)C=NC2=C1 UEFKMJWKPVAVND-UHFFFAOYSA-N 0.000 title 1
- 150000002148 esters Chemical class 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 150000003839 salts Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Quinoline Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US2398179A | 1979-03-26 | 1979-03-26 | |
| US06/127,153 US4343804A (en) | 1979-03-26 | 1980-03-04 | 4-Amino-3-quinolinecarboxylic acids and esters-antisecretory anti-ulcer compounds |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IL59628A0 IL59628A0 (en) | 1980-06-30 |
| IL59628A true IL59628A (en) | 1983-06-15 |
Family
ID=26697875
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL59628A IL59628A (en) | 1979-03-26 | 1980-03-14 | 4-amino-3-quinolinecarboxylic acids and salts and esters thereof and pharmaceutical compositions containing them |
Country Status (31)
| Country | Link |
|---|---|
| US (1) | US4343804A (OSRAM) |
| JP (1) | JPH02117663A (OSRAM) |
| AR (1) | AR230268A1 (OSRAM) |
| AT (1) | AT372373B (OSRAM) |
| AU (1) | AU528388B2 (OSRAM) |
| BR (1) | BR8001779A (OSRAM) |
| CA (1) | CA1147338A (OSRAM) |
| CH (1) | CH644105A5 (OSRAM) |
| DE (1) | DE3011490A1 (OSRAM) |
| DK (1) | DK156056C (OSRAM) |
| EG (1) | EG15009A (OSRAM) |
| ES (1) | ES8103048A1 (OSRAM) |
| FI (1) | FI77452C (OSRAM) |
| FR (1) | FR2452485B1 (OSRAM) |
| GB (1) | GB2047244B (OSRAM) |
| GR (1) | GR68006B (OSRAM) |
| HK (1) | HK67983A (OSRAM) |
| IE (1) | IE49577B1 (OSRAM) |
| IL (1) | IL59628A (OSRAM) |
| IN (1) | IN151446B (OSRAM) |
| IT (1) | IT1133079B (OSRAM) |
| MX (1) | MX6264E (OSRAM) |
| NL (1) | NL8001752A (OSRAM) |
| NO (1) | NO153927C (OSRAM) |
| NZ (1) | NZ193252A (OSRAM) |
| PH (1) | PH16416A (OSRAM) |
| PL (1) | PL125030B1 (OSRAM) |
| PT (1) | PT71008B (OSRAM) |
| SE (1) | SE435837B (OSRAM) |
| SG (1) | SG33683G (OSRAM) |
| YU (1) | YU41702B (OSRAM) |
Families Citing this family (44)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8610981D0 (en) * | 1986-05-06 | 1986-06-11 | Ici America Inc | Quinoline amides |
| GB8621425D0 (en) * | 1986-09-05 | 1986-10-15 | Smith Kline French Lab | Compounds |
| GB8804445D0 (en) * | 1988-02-25 | 1988-03-23 | Smithkline Beckman Intercredit | Compounds |
| GB8804447D0 (en) * | 1988-02-25 | 1988-03-23 | Smithkline Beckman Intercredit | Compounds |
| GB8804443D0 (en) * | 1988-02-25 | 1988-03-23 | Smithkline Beckman Intercredit | Compounds |
| GB8804448D0 (en) * | 1988-02-25 | 1988-03-23 | Smithkline Beckman Intercredit | Compounds |
| GB8804444D0 (en) * | 1988-02-25 | 1988-03-23 | Smithkline Beckman Intercredit | Compounds |
| GB8804446D0 (en) * | 1988-02-25 | 1988-03-23 | Smithkline Beckman Intercredit | Compounds |
| US5432182A (en) * | 1989-02-23 | 1995-07-11 | Smithkline Beecham Intercredit B.V. | Compounds substituted quinoline derivatives |
| CA2011086A1 (en) * | 1989-03-17 | 1990-09-17 | Karl-Heinz Geiss | 2-alkyl-4-arylmethylaminoquinolines, the use thereof and drugs prepared therefrom |
| DE3917233A1 (de) * | 1989-05-26 | 1990-11-29 | Basf Ag | 8-substituierte 4-(heterocyclylmethylamino)-chinoline, ihre verwendung und daraus hergestellte arzneimittel |
| GB8918265D0 (en) * | 1989-08-10 | 1989-09-20 | Smithkline Beckman Intercredit | Compounds |
| US5362743A (en) * | 1993-03-09 | 1994-11-08 | Pfizer Inc. | Aminoquinoline derivatives |
| US5556863A (en) * | 1993-06-11 | 1996-09-17 | Astra Aktiebolag | Compound for gastric acid secretion inhibition |
| IS4164A (is) * | 1993-06-11 | 1994-12-12 | Ab Astra | Efnasambönd sem hindra flæði magasýru |
| WO1995004720A2 (en) * | 1993-08-10 | 1995-02-16 | Black James Foundation | Gastrin and cck receptor ligands |
| US5650415A (en) * | 1995-06-07 | 1997-07-22 | Sugen, Inc. | Quinoline compounds |
| KR0169813B1 (ko) * | 1995-07-12 | 1999-01-15 | 김종인 | 4-아미노-3-아실나프티리딘 유도체 |
| US5760041A (en) * | 1996-02-05 | 1998-06-02 | American Cyanamid Company | 4-aminoquinazoline EGFR Inhibitors |
| US6875769B2 (en) * | 1996-05-23 | 2005-04-05 | Pfizer Inc. | Substituted6,6-hetero-bicyclicderivatives |
| US5929080A (en) * | 1997-05-06 | 1999-07-27 | American Cyanamid Company | Method of treating polycystic kidney disease |
| US6251912B1 (en) | 1997-08-01 | 2001-06-26 | American Cyanamid Company | Substituted quinazoline derivatives |
| US6323209B1 (en) | 1997-11-06 | 2001-11-27 | American Cyanamid Company | Method of treating or inhibiting colonic polyps |
| EP1117649A1 (en) | 1998-09-29 | 2001-07-25 | American Cyanamid Company | Substituted 3-cyanoquinolines as protein tyrosine kinases inhibitors |
| CN1217936C (zh) * | 1999-12-28 | 2005-09-07 | 卫材株式会社 | 含有磺酰胺的杂环化合物 |
| US6521618B2 (en) | 2000-03-28 | 2003-02-18 | Wyeth | 3-cyanoquinolines, 3-cyano-1,6-naphthyridines, and 3-cyano-1,7-naphthyridines as protein kinase inhibitors |
| US6576644B2 (en) * | 2000-09-06 | 2003-06-10 | Bristol-Myers Squibb Co. | Quinoline inhibitors of cGMP phosphodiesterase |
| UA80393C2 (uk) | 2000-12-07 | 2007-09-25 | Алтана Фарма Аг | Фармацевтична композиція, яка містить інгібітор фде 4, диспергований в матриці |
| MY140561A (en) * | 2002-02-20 | 2009-12-31 | Nycomed Gmbh | Dosage form containing pde 4 inhibitor as active ingredient |
| PL377847A1 (pl) | 2003-01-14 | 2006-02-20 | Arena Pharmaceuticals Inc. | 1,2,3-Tripodstawione pochodne arylowe i heteroarylowe jako modulatory metabolizmu oraz profilaktyka i leczenie związanych z nim zaburzeń takich jak cukrzyca i hiperglikemia |
| PL1606261T3 (pl) | 2003-03-10 | 2010-04-30 | Astrazeneca Ab | Nowy sposób przygotowania roflumilastu |
| KR20060056944A (ko) * | 2003-07-14 | 2006-05-25 | 아레나 파마슈티칼스, 인크. | 대사 조절제로서 융합된 아릴 및 헤테로아릴 유도체 및이에 관련된 장애의 예방 또는 치료 |
| EP1861074B1 (en) * | 2005-03-16 | 2013-04-24 | Takeda GmbH | Taste masked dosage form containing roflumilast |
| WO2011022216A1 (en) * | 2009-08-17 | 2011-02-24 | High Point Pharmaceuticals, Llc | Substituted pyridine derivatives, pharmaceutical compositions, and methods of use to treat oxidative stress |
| CN108558740B (zh) | 2010-01-27 | 2021-10-19 | 艾尼纳制药公司 | S1p1受体调节剂及其盐的制备方法 |
| CA2812061A1 (en) | 2010-09-22 | 2012-03-29 | Arena Pharmaceuticals, Inc. | Modulators of the gpr119 receptor and the treatment of disorders related thereto |
| US11007175B2 (en) | 2015-01-06 | 2021-05-18 | Arena Pharmaceuticals, Inc. | Methods of treating conditions related to the S1P1 receptor |
| KR102883123B1 (ko) | 2015-06-22 | 2025-11-10 | 아레나 파마슈티칼스, 인크. | Ｓ1ｐ1 수용체-관련 장애에서의 사용을 위한 (ｒ)-2-(7-(4-시클로펜틸-3-(트리플루오로메틸)벤질옥시)-1,2,3,4-테트라히드로시클로-펜타[ｂ]인돌-3-일)아세트산 (화합물 1)의 결정성 ｌ-아르기닌 염 |
| AU2017357503B2 (en) * | 2016-11-11 | 2022-02-17 | Elanco Animal Health Gmbh | New anthelmintic quinoline-3-carboxamide derivatives |
| MA47504A (fr) | 2017-02-16 | 2019-12-25 | Arena Pharm Inc | Composés et méthodes de traitement de l'angiocholite biliaire primitive |
| EP3700527A4 (en) * | 2017-10-25 | 2021-03-10 | Children's Medical Center Corporation | PAPD5 INHIBITORS AND METHOD OF USING THEM |
| US11572357B2 (en) | 2018-05-09 | 2023-02-07 | Bayer Animal Health Gmbh | Quinoline derivatives |
| WO2019236757A1 (en) | 2018-06-06 | 2019-12-12 | Arena Pharmaceuticals, Inc. | Methods of treating conditions related to the s1p1 receptor |
| JP7617020B2 (ja) | 2019-04-24 | 2025-01-17 | チルドレンズ メディカル センター コーポレイション | Ｐａｐｄ５阻害剤およびその使用方法 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3470186A (en) * | 1967-06-02 | 1969-09-30 | American Cyanamid Co | Substituted 4-anilino-3-quinolinecarboxylic acids and esters |
| JPS4838712A (OSRAM) * | 1971-09-18 | 1973-06-07 |
-
1980
- 1980-03-04 US US06/127,153 patent/US4343804A/en not_active Expired - Lifetime
- 1980-03-14 IL IL59628A patent/IL59628A/xx unknown
- 1980-03-22 GR GR61513A patent/GR68006B/el unknown
- 1980-03-24 FR FR8006516A patent/FR2452485B1/fr not_active Expired
- 1980-03-24 FI FI800910A patent/FI77452C/fi not_active IP Right Cessation
- 1980-03-24 MX MX808722U patent/MX6264E/es unknown
- 1980-03-24 AT AT0156480A patent/AT372373B/de not_active IP Right Cessation
- 1980-03-24 IE IE605/80A patent/IE49577B1/en unknown
- 1980-03-25 NO NO800858A patent/NO153927C/no unknown
- 1980-03-25 DK DK128380A patent/DK156056C/da not_active IP Right Cessation
- 1980-03-25 EG EG80174A patent/EG15009A/xx active
- 1980-03-25 CH CH234080A patent/CH644105A5/fr not_active IP Right Cessation
- 1980-03-25 NL NL8001752A patent/NL8001752A/nl not_active Application Discontinuation
- 1980-03-25 DE DE19803011490 patent/DE3011490A1/de active Granted
- 1980-03-25 PL PL1980222993A patent/PL125030B1/pl unknown
- 1980-03-25 IN IN345/CAL/80A patent/IN151446B/en unknown
- 1980-03-25 GB GB8009991A patent/GB2047244B/en not_active Expired
- 1980-03-25 PT PT71008A patent/PT71008B/pt unknown
- 1980-03-25 ES ES489887A patent/ES8103048A1/es not_active Expired
- 1980-03-25 BR BR8001779A patent/BR8001779A/pt unknown
- 1980-03-25 PH PH23804A patent/PH16416A/en unknown
- 1980-03-25 NZ NZ193252A patent/NZ193252A/en unknown
- 1980-03-25 SE SE8002292A patent/SE435837B/sv not_active IP Right Cessation
- 1980-03-26 AU AU56848/80A patent/AU528388B2/en not_active Ceased
- 1980-03-26 AR AR280455A patent/AR230268A1/es active
- 1980-03-26 CA CA000348417A patent/CA1147338A/en not_active Expired
- 1980-03-26 YU YU844/80A patent/YU41702B/xx unknown
- 1980-03-26 IT IT67465/80A patent/IT1133079B/it active
-
1983
- 1983-06-13 SG SG336/83A patent/SG33683G/en unknown
- 1983-12-15 HK HK679/83A patent/HK67983A/xx unknown
-
1989
- 1989-09-26 JP JP1250369A patent/JPH02117663A/ja active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL59628A0 (en) | 4-amino-3-quinolinecarboxylic acids and salts and esters thereof and pharmaceutical compositions containing them | |
| IL60422A (en) | Formylhydroxyphenoxy pentanoic and methylbenzoic acids and derivatives thereof,their preparation and pharmaceutical compositions containing them | |
| IL56991A0 (en) | 4-halo-3-oxoandrost-4-ene-17 -thiocarboxylic acid esters their preparation and pharmaceutical compositions containing them | |
| IL64185A0 (en) | 1-carboxy-azaalkanoylindoline-2-carboxylic acids and ester and amide derivatives thereof,their manufacture and pharmaceutical compositions containing them | |
| IL78528A0 (en) | Difluoro-naphthyridine-and trifluoro-quinoline-carboxylic acids and esters and salts thereof and pharmaceutical compositions containing them | |
| NZ189296A (en) | N-substituted-omega-aminoalkanoyl-omega-aminoalkanoic acids and pharmaceutical compositions | |
| DE3064453D1 (en) | Isoquinoline acetic acids and pharmaceutical compositions thereof | |
| NZ190842A (en) | 4-substituted-thiazole-2-oxamic acids and esters and pharmaceutical compositions | |
| ZA822933B (en) | Aminocyclopentanol acids and esters and their preparation and pharmaceutical formulation | |
| IL61210A0 (en) | 3-benzoyl-2-nitrophenylacetic acids and metal salts, amides and esters thereof and pharmaceutical compositions containing them | |
| GB2057427B (en) | Oxoimidazolinealkanoic acids and their salts and esters their preparation and pharmaceutical compositions containing them | |
| NZ190521A (en) | Phenylamino-thiophenacetic acids and pharmaceutical compositions | |
| IL52820A0 (en) | New acylated heterocyclylcarboxylic acids and salts thereof their preparation and pharmaceutical compositions containing them | |
| NZ194784A (en) | 7 -aminothiadizolylacetylamino-3-cephem-4-carboxylic acid derivatives and pharmaceutical compositions | |
| IL55152A0 (en) | 7-acylamido-3-cephem-4-carboxylic acids and esters and salts thereof,their preparation and pharmaceutical compositions containing them | |
| NZ194241A (en) | 7b-aminothiadiazolylacetamido-3-cephem-4 carboxylic acid derivatives and pharmaceutical compositions | |
| NZ185511A (en) | 2-(2-amidoethylidene)-clavam-3-carboxylic acids salts and esters and pharmaceutical compositions | |
| DE2967551D1 (en) | 5(6)-(2-amino-5-thiazoloyl)benzimidazole-2-carbamic acid esters and their salts, their preparation and use, and pharmaceutical compositions containing them | |
| JPS5692843A (en) | Nnsubstituted alphaaamino acids*their manufacture and medicinal composition containing them | |
| NZ194122A (en) | Acylaminobenzoic acid derivatives and pharmaceutical compositions | |
| PH14995A (en) | Oxaminic acids and esters thereof and pharmaceutical compositions containing these compounds | |
| NZ187474A (en) | 4-heterocyclyl-piperazine-i-carbodithioic acids and salts and pharmaceutical compositions thereof | |
| NZ189295A (en) | N-substituted-acyl-aminoalkanoic acids and pharmaceutical compositions | |
| IL52952A0 (en) | New hydroxymethyl-pyridine esters their preparation and pharmaceutical compositions containing them | |
| IL58154A0 (en) | 1-methyl-4-piperidinol esters their preparation and pharmaceutical compositions containing them |